Literature DB >> 2406230

A CT-based computerized treatment planning system for I-125 stereotactic brain implants.

K Weaver1, V Smith, J D Lewis, B Lulu, C M Barnett, S A Leibel, P Gutin, D Larson, T Phillips.   

Abstract

A computer program has been developed at the University of California, San Francisco, as an aid in planning and evaluating stereotactic brain implants made with 125I seeds. The program allows images of seeds and catheters to be positioned in the target volume revealed by CT. It then generates and displays the resulting isodose distributions. Catheters may be changed interactively until an optimum implant is achieved. From the geometry of a stereotactic implant frame as measured by CT, the program calculates the approach angles of the catheters in the frame coordinate system. After the seeds are implanted, films made with a fiducial marker box can be used to generate true seed positions and hence true isodoses. This paper describes mathematically the geometrical transformations used by the program, and also outlines its many features and options. In its first 2 years of use the program has proved to be a valuable contributor to improved patient care.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2406230     DOI: 10.1016/0360-3016(90)90114-y

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  4 in total

Review 1.  Interstitial brachytherapy and hyperthermia for malignant gliomas.

Authors:  P H Gutin; D C Shrieve; D A Larson; P Sneed
Journal:  J Neurooncol       Date:  1993-08       Impact factor: 4.130

Review 2.  Brachytherapy for brain tumors.

Authors:  Todd W Vitaz; Peter C Warnke; Viviane Tabar; Philip H Gutin
Journal:  J Neurooncol       Date:  2005-05       Impact factor: 4.130

3.  Use of the Brown-Roberts-Wells Stereotactic Frame in a Developing Country.

Authors:  Ali S Khedr; Armando L Alaminos-Bouza; Russell A Brown
Journal:  Cureus       Date:  2018-01-29

Review 4.  Iodine-125 brachytherapy for brain tumours--a review.

Authors:  Silke B Schwarz; Niklas Thon; Katharina Nikolajek; Maximilian Niyazi; Joerg-Christian Tonn; Claus Belka; Friedrich-Wilhelm Kreth
Journal:  Radiat Oncol       Date:  2012-03-06       Impact factor: 3.481

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.